<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=6988090&amp;fmt=gif">

October 13, 2026

Scantox Neuro Symposium Boston

  • days
  • Hours
  • Minutes
  • Seconds

October 13, 2026

Scantox Neuro Symposium Boston

  • days
  • Hours
  • Minutes
  • Seconds

Date

March 10-13, 2023

Date

March 10-13, 2023

Date

March 10-13, 2023

Date

March 10-13, 2023

ABOUT THE EVENT

Join Scantox and invited scientific experts for a half-day symposium exploring current approaches to modeling neurodegenerative diseases across the preclinical discovery pipeline. Examine how neuroinflammation, shared biomarker networks, lysosomal dysfunction, human-relevant NAMs, advanced in vitro systems, and established in vivo models can be integrated to strengthen translational research in Alzheimer’s, Parkinson’s, and related neurological disorders.

Whether you are investigating disease mechanisms, selecting appropriate models, evaluating translational biomarkers, or advancing an early-stage therapeutic program, this event will deliver practical insights into building integrated preclinical strategies that support stronger scientific decisions and reduce development risk.

DONATION / meet with greaters

Praesent ac sem in neque venenatis tristique. Morbi et ligula velit. Nullam a augue vel mi porta vestibulum non ac elit. Vivamus convallis tortor et fermentum semper

WHO SHOULD ATTEND

This symposium is designed for scientists and leaders working across CNS discovery, preclinical development, and translational research, including:

  • Neuroscientists investigating neuroinflammation, lysosomal dysfunction, disease mechanisms, and shared pathological pathways in Alzheimer’s, Parkinson’s, and related neurodegenerative disorders
  • Drug discovery teams evaluating human-relevant NAMs, advanced in vitro systems, in vivo models, and translational biomarkers
  • Preclinical R&D professionals from biotechnology, pharmaceutical companies, regulatory consulting, and academia seeking to strengthen model selection, efficacy assessment, and translational decision-making

(Please note: this meeting is intended for professionals directly involved in CNS drug discovery and development to ensure discussions remain focused and valuable.)

Symposium Agenda

Lone Bruhn Madsen

Opening Remarks

Speaker Image HubSpot seb - w002

Session 1: Modeling Neuroinflammation Across Neurodegenerative Diseases: From Cellular Mechanisms to Translational Readouts

This session will outline approaches for modeling neuroinflammation across neurodegenerative diseases, highlighting in vitro and in vivo systems for investigating microglial activation, astrocyte responses, immune-cell infiltration, cytokine signaling, and phagocytosis, and discussing how complementary biochemical, histological, cellular, and molecular readouts can strengthen mechanistic and translational research.

Lone Bruhn Madsen

Session 2a: The Göttingen Minipig in Drug Discovery and Development - Applying the Model in an Obesity Context

This session will examine the Göttingen Minipig as a translational large-animal model, using obesity research to illustrate its application across pharmacology, CNS development, PK/PD assessment, and regulatory toxicology, and discussing how flexible administration routes, longitudinal sampling, biomarker evaluation, and clinically relevant pharmacokinetic data can support progression from discovery through preclinical development.

Tina Loeffler PhD - Scantox

Session 2b: Shared Biomarker Networks Across Models of Neurodegeneration and Lysosomal Dysfunction

This session will examine shared and disease-specific biomarker patterns across mouse models of Alzheimer’s disease, Parkinson’s disease, and lysosomal storage disorders, highlighting changes in protein aggregation, neuroinflammation, lysosomal function, synaptic integrity, and cellular senescence, and discussing how comparative biomarker profiling can strengthen model selection, mechanistic investigation, and translational drug discovery.

Tina Loeffler PhD - Scantox

Session 3: Bridging Mechanism to Efficacy: Integrating NAMs with In Vivo Models to De-risk Alzheimer’s and Parkinson’s Drug Discovery

This session will outline strategies for model selection based on therapeutic modality, target biology, and mechanism of action, highlighting mechanistic assays, human iPSC-derived systems, advanced 3D Neurospheres, and established in vivo models for Alzheimer’s and Parkinson’s disease, and discussing how integrated model cascades and data interpretation can strengthen early-stage decisions and reduce development risk.

Thierry Bussiere

Developing a New Molecule for the Treatment of Alzheimer's Disease: Choosing the Appropriate Mouse Models to Reliably Inform Human Endpoints

Using the development of aducanumab as a case study, this session will examine how Alzheimer’s disease mouse models have evolved and why model selection should be driven by the human endpoints a program needs to inform. It will explore how different models address distinct translational questions, how mouse data should be interpreted against clinically relevant outcomes, and the inherent limitations of current AD models.

2025-10, PRC - LI

Closing Remarks

lunch at the Grad Cam

Lunch & Networking

EVENT PRESENTERS

EVENT SPEAKERS / meet with greaters

successful-professional-enjoying-work-break
SPEAKER NAME
CO FOUNDER

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed vel velit

portrait-excited-african-girl-pink-casual-clothes-using-laptop-pc-computer-isolated-blue-turquoise-wall-background-studio-people-sincere-emotions-lifestyle-concept-mock-up-copy-space
SPEAKER NAME
CO FOUNDER

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed vel velit

portrait-cheerful-excited-tablet-user-wearing-eyeglasses
SPEAKER NAME
CO FOUNDER

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed vel velit

avatar-v2-4
SPEAKER NAME
CO FOUNDER

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed vel velit

EVENT PRICE LIST / perfect price for event

personal

111$
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
Best

company

124$
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet

business

175$
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet
  • Lorem ipsum dolor sit amet

EVENT FAQS / find your answers

Vestibulum sit amet tincidunt urna, eget ullamcorper purus. Aenean feugiat quis tortor vitae fringilla. Pellentesque augue nisl, condimentum at sem et, fermentum varius ligula. Nulla dignissim nulla eget congue cursus.

  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature

Vestibulum sit amet tincidunt urna, eget ullamcorper purus. Aenean feugiat quis tortor vitae fringilla. Pellentesque augue nisl, condimentum at sem et, fermentum varius ligula. Nulla dignissim nulla eget congue cursus.

  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature

Vestibulum sit amet tincidunt urna, eget ullamcorper purus. Aenean feugiat quis tortor vitae fringilla. Pellentesque augue nisl, condimentum at sem et, fermentum varius ligula. Nulla dignissim nulla eget congue cursus.

  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature

Vestibulum sit amet tincidunt urna, eget ullamcorper purus. Aenean feugiat quis tortor vitae fringilla. Pellentesque augue nisl, condimentum at sem et, fermentum varius ligula. Nulla dignissim nulla eget congue cursus.

  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature
  • First Awesome Feature

DONATION / meet with greaters

Praesent ac sem in neque venenatis tristique. Morbi et ligula velit. Nullam a augue vel mi porta vestibulum non ac elit. Vivamus convallis tortor et fermentum semper

RECENT BLOG POSTS / get news

THE VENUE

MassBioHub


700 Technology Square, 5th Floor
Cambridge, MA 02139
+1 (617) 674-5100

marketing@scantox.com

CONTACT US TODAY

Reserve your spot by submitting the registration form below.